A comprehensive view of Oral Medicines/Supplements. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Medicines Agency accepts GSK's marketing authorization application for momelotinib for the treatment of myelofibrosis, a type of bone marrow cancer; myelofibrosis affects approximately 20,000 patients in the US

Sorrento Therapeutics reports its STI-1558 experimental oral COVID-19 drug shows initial signs of efficacy in two early-stage studies; in one study treatment reduced viral RNA load by the third day

Nestle mulls options for peanut allergy drug Palforzia after slow adoption by patients, healthcare professionals; Palforzia is only oral immunotherapy approved by FDA to reduce allergic reactions to peanuts

Kyowa Kirin divests 13 mature brands to Grunenthal in deal worth US$83.0M, plus royalties; products include Abstral fentanyl sublingual tablets, PecFent fentanyl nasal spray, Moventig naloxegol, Adcal-D3 calcium and vitamin D3 for osteoporosis

Health Canada approves Bristol Myers Squibb’s Sotyktu deucravacitinib tablets to treat severe plaque psoriasis in adults; Psoriasis is a chronic inflammatory condition that affects nearly a million Canadians

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count